RAPTOR PHARMACEUTICAL CORP's ticker is RPTP and the CUSIP is 75382F106.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $2,972,000 | +67.2% | 331,351 | +0.1% | 0.00% | +100.0% |
| Q2 2016 | $1,777,000 | +33.8% | 330,867 | +14.6% | 0.00% | 0.0% |
| Q1 2016 | $1,328,000 | -10.5% | 288,637 | +1.2% | 0.00% | 0.0% |
| Q4 2015 | $1,483,000 | -14.1% | 285,237 | -0.1% | 0.00% | 0.0% |
| Q3 2015 | $1,727,000 | -61.8% | 285,467 | -0.2% | 0.00% | -66.7% |
| Q2 2015 | $4,516,000 | +105.8% | 285,995 | +41.7% | 0.01% | +100.0% |
| Q1 2015 | $2,194,000 | +14.8% | 201,819 | +11.1% | 0.00% | 0.0% |
| Q4 2014 | $1,911,000 | +9.3% | 181,680 | -0.3% | 0.00% | +50.0% |
| Q3 2014 | $1,748,000 | -16.2% | 182,289 | +0.9% | 0.00% | -33.3% |
| Q2 2014 | $2,087,000 | +26.3% | 180,730 | +9.4% | 0.00% | +50.0% |
| Q1 2014 | $1,653,000 | -22.3% | 165,265 | +1.1% | 0.00% | -33.3% |
| Q4 2013 | $2,128,000 | -14.5% | 163,459 | -2.1% | 0.00% | -25.0% |
| Q3 2013 | $2,490,000 | +81.0% | 166,909 | +13.4% | 0.00% | +100.0% |
| Q2 2013 | $1,376,000 | – | 147,125 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Trellus Management Company, LLC | 63,500 | $1,003,000 | 1.13% |
| Broadfin Capital, LLC | 1,319,883 | $20,841,000 | 1.12% |
| BAILARD, INC. | 160,000 | $2,526,000 | 0.39% |
| Birchview Capital, LP | 46,000 | $726,000 | 0.38% |
| HIGHLAND CAPITAL MANAGEMENT LP | 1,182,167 | $18,666,000 | 0.38% |
| Rock Springs Capital Management LP | 305,000 | $4,816,000 | 0.35% |
| SPHERA FUNDS MANAGEMENT LTD. | 206,500 | $3,261,000 | 0.32% |
| GLOBEFLEX CAPITAL L P | 109,771 | $1,733,000 | 0.32% |
| GROUP ONE TRADING, L.P. | 1,319,766 | $20,839,000 | 0.29% |
| Perceptive Advisors | 264,204 | $4,172,000 | 0.25% |